The Parker Institute for Cancer Immunotherapy, a collaborative consortium of immuno-oncology experts that bridges scientific discovery and commercialization of cancer therapies, announced its 2025 class of Early Career Researcher awardees.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe